SCHEMBL24540338

SCHEMBL24540338

CCOC(=O)Cc1cc(C(C)C)on1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 6/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.39
TSHR P16473 1/20 0.38
EPHX2 P34913 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653949 0.86 MEN1 (0.43) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL18623686 0.82 NPC1 (0.50) MEN1KMT2AALDH1A1TP53SMN1; SMN2
SCHEMBL24540340 0.77 KDM4E (0.44) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL17653916 0.76 HDAC4 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL1090847 0.76 THRB (0.59) THRBMEN1KMT2AALDH1A1TP53
SCHEMBL27163685 0.74 NOTUM (0.55) THRBALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL10271203 0.72 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL23559144 0.71 THRB (0.46) THRBMEN1KMT2AALDH1A1TP53
SCHEMBL19598756 0.71 PPARA (0.45) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL17653863 0.71 MEN1 (0.43) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022133027-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-06-23 WO disclosed